Skip to main content

Published locations for FDA approves cabozantinib for the frontline treatment of advanced RCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves cabozantinib for the frontline treatment of advanced RCC

User login

  • Reset your password
  • /content/fda-approves-cabozantinib-frontline-treatment-advanced-rcc
  • /oncologypractice/article/155016/renal-cell-carcinoma/fda-approves-cabozantinib-frontline-treatment
  • /hematology-oncology/article/155016/renal-cell-carcinoma/fda-approves-cabozantinib-frontline